NCT07187934

Brief Summary

This study aims to investigate whether embryo ranking by a fully automated AI tool (iDAScore) results in a similar transfer-to-pregnancy compared to manual embryo ranking by an embryologist. IVF patients who are planned for a freeze-all approach (where all usable embryos are frozen and transferred in later transfer cycles) will be allocated to either the control (ranking by embryologist) or intervention arm (ranking by iDAScore). The frozen embryos will be warmed and transferred one by one, according to their assigned rank. We want to see if the average number of embryo transfers that is needed to achieve a clinical pregnancy (transfer-to-pregnancy) is similar in both groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,325

participants targeted

Target at P75+ for not_applicable pregnancy

Timeline
41mo left

Started Dec 2025

Longer than P75 for not_applicable pregnancy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Dec 2025Oct 2029

First Submitted

Initial submission to the registry

September 4, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 23, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

December 11, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2028

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2029

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

3 years

First QC Date

September 4, 2025

Last Update Submit

December 16, 2025

Conditions

Keywords

iDAAIembryo rankingtransfer-to-pregnancytime-lapse

Outcome Measures

Primary Outcomes (1)

  • Transfer to pregnancy

    Number of embryo transfers performed until a clinical pregnancy is obtained

    The patient is followed up for clinical pregnancy outcomes (7-week echo) up until 1 year after the oocyte retrieval date, or until the result of the last available embryo is known.

Secondary Outcomes (4)

  • iDA-embryologist consensus

    Embryo ranking is done on day 5 and/or 6 of embryo development and can be immediately compared during ranking.

  • Embryo prioritization time

    Measures the time elapsing between the start and end of embryo prioritisation (range of minutes). Is recorded on day 5 and day 6 of embryo development right after embryo evaluation.

  • Cumulative clinical pregnancy rate

    Up until 1 year after oocyte retrieval

  • Clinical pregnancy rate after the first embryo transfer

    Clinical pregnancy is determined at the 7 week echo by detection of a fetal heart beat.

Study Arms (2)

Embryologist ranking

NO INTERVENTION

Embryologist ranks the embryos according to their appearance

iDA ranking

EXPERIMENTAL

AI tool ranks embryos based on fully automated analysis of time-lapse images

Device: AI algorithm

Interventions

iDAScore® is a deep learning-based tool that provides fully automated analysis of embryo time-lapse images. It automatically generates a score (1-9.9) for each embryo in the patient's embryo cohort, which correlates to the likelihood of achieving a fetal heartbeat (clinical pregnancy).

Also known as: iDAScore
iDA ranking

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female participants can undergo an oocyte retrieval.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • patients undergoing an ICSI/IVF treatment (with donor or own oocytes) that are planned for a 'freeze-all' strategy on day 5
  • all types of sperm samples (ejaculated or testicular, fresh or frozen, partner or donor origin)
  • Minimum 8 follicles (≥ 12 mm) on last follicular measurement before oocyte retrieval
  • ≤ Age ≤ 42 years
  • ≤ BMI ≤ 35 kg/m²
  • Maximum third IVF/ICSI cycle
  • Participants can be included only once in the trial

You may not qualify if:

  • Embassy patients
  • Use of frozen oocytes
  • In vitro maturation (IVM) cycles
  • Pre-implantation genetic Testing (PGT) cycles
  • Proven untreated intra-uterine pathologies (e.g. Asherman syndrome, adenomysosis)
  • Endometriosis stage 3/4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brussels IVF, UZ Brussel

Brussels, Brussels Capital, 1090, Belgium

RECRUITING

Related Links

Study Officials

  • Julie Praet, M.D.

    Brussels IVF, UZ Brussel

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Randomisation (1:1) based on a computer-generated randomisation list with block size 10.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2025

First Posted

September 23, 2025

Study Start

December 11, 2025

Primary Completion (Estimated)

December 11, 2028

Study Completion (Estimated)

October 1, 2029

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations